Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,042 | Dovepress* | 11,232+ | 1,883 | 13,115 | |
PubMed Central* | 810 | 396 | 1,206 | ||
Totals | 12,042 | 2,279 | 14,321 | ||
*Since 25 February 2015 +Since July 2016 |
View citations on PubMed and Google Scholar